Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Multiple Endocrine Neoplasia × Leflunomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Pancreatic Neoplasms 2 PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer 1 Neuroendocrine Tumors 1 Neoplasms 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia 1 Melanoma 1 Lung Neoplasms 1 Colorectal Neoplasms 1 Acute Graft Versus Host Disease 1

Interventions

Surveys and Questionnaires 1 Leflunomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06540937 2024-08-07

Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Recruiting

Multiple Endocrine Neoplasia, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡